FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981866712> ?p ?o ?g. }

• W1981866712 endingPage "89" @default.
• W1981866712 startingPage "83" @default.
• W1981866712 abstract "The incidence of breast cancer is increasing worldwide, and this seems to be related to an increase in lifestyle risk factors, including physical inactivity and overweight/obesity. We have reported previously that exercise induced a circulating angiostatic phenotype characterized by increased soluble fms-like tyrosine kinase-1 (sFlt-1) and endostatin and decreased unbound vascular endothelial growth factor (VEGF) in men. However, there are no data on women. The present study determines the following: (a) whether moderate exercise increased sFlt-1 and endostatin and decreased unbound VEGF in the circulation of adult female volunteers and (b) whether overweight/obese women have a higher plasma level of unbound VEGF than lean women. A total of 72 African American and White adult women volunteers ranging in age from 18 to 44 years were enrolled in the exercise study. All the participants walked on a treadmill for 30 min at a moderate intensity (55-59% heart rate reserve), and oxygen consumption (VO(2)) was quantified utilizing a metabolic cart. We obtained blood samples before and immediately after exercise from 63 participants. ELISA assays showed that the plasma levels of sFlt-1 were 67.8±3.7 pg/ml immediately after exercise (30 min), significantly higher than the basal levels, 54.5±3.3 pg/ml, before exercise (P<0.01; n=63). There was no significant difference in the % increase in the sFlt-1 levels after exercise between African American and White (P=0.533) women or between lean and overweight/obese women (P=0.892). There was no significant difference in the plasma levels of unbound VEGF (35.28±5.47 vs. 35.23±4.96 pg/ml; P=0.99) or endostatin (111.12±5.48 vs. 115.45±7.15 ng/ml; P=0.63) before and after exercise. The basal plasma levels of unbound VEGF in overweight/obese women were 52.26±9.6 pg/ml, significantly higher than the basal levels of unbound VEGF in lean women, 27.34±4.99 pg/ml (P<0.05). The results support our hypothesis that exercise-induced plasma levels of sFlt-1 could be an important clinical biomarker to explore the mechanisms of exercise training in reducing the progression of breast cancer and that VEGF is an important biomarker in obesity and obesity-related cancer progression." @default.
• W1981866712 created "2016-06-24" @default.
• W1981866712 creator A5003315698 @default.
• W1981866712 creator A5009081262 @default.
• W1981866712 creator A5010788589 @default.
• W1981866712 creator A5014827216 @default.
• W1981866712 creator A5021330317 @default.
• W1981866712 creator A5039423116 @default.
• W1981866712 creator A5041301571 @default.
• W1981866712 creator A5044087654 @default.
• W1981866712 creator A5070534421 @default.
• W1981866712 creator A5087485359 @default.
• W1981866712 creator A5087598755 @default.
• W1981866712 date "2013-01-01" @default.
• W1981866712 modified "2023-10-04" @default.
• W1981866712 title "Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women" @default.
• W1981866712 cites W1572578420 @default.
• W1981866712 cites W1787433625 @default.
• W1981866712 cites W1963592300 @default.
• W1981866712 cites W1969874649 @default.
• W1981866712 cites W1976491554 @default.
• W1981866712 cites W1981508911 @default.
• W1981866712 cites W1984428595 @default.
• W1981866712 cites W1985804036 @default.
• W1981866712 cites W1986469266 @default.
• W1981866712 cites W1991994014 @default.
• W1981866712 cites W1994525965 @default.
• W1981866712 cites W1994567670 @default.
• W1981866712 cites W1999758029 @default.
• W1981866712 cites W2000292756 @default.
• W1981866712 cites W2010199313 @default.
• W1981866712 cites W2014929279 @default.
• W1981866712 cites W2018896405 @default.
• W1981866712 cites W2019174237 @default.
• W1981866712 cites W2025251060 @default.
• W1981866712 cites W2031313208 @default.
• W1981866712 cites W2032883806 @default.
• W1981866712 cites W2033048967 @default.
• W1981866712 cites W2057110290 @default.
• W1981866712 cites W2057521345 @default.
• W1981866712 cites W2062925685 @default.
• W1981866712 cites W2063503252 @default.
• W1981866712 cites W2070821645 @default.
• W1981866712 cites W2072928113 @default.
• W1981866712 cites W2081703950 @default.
• W1981866712 cites W2082151578 @default.
• W1981866712 cites W2086619383 @default.
• W1981866712 cites W2090673901 @default.
• W1981866712 cites W2097547262 @default.
• W1981866712 cites W2104485396 @default.
• W1981866712 cites W2107689453 @default.
• W1981866712 cites W2109521263 @default.
• W1981866712 cites W2110675408 @default.
• W1981866712 cites W2112395080 @default.
• W1981866712 cites W2119043639 @default.
• W1981866712 cites W2129339554 @default.
• W1981866712 cites W2140476817 @default.
• W1981866712 cites W2142377643 @default.
• W1981866712 cites W2145875868 @default.
• W1981866712 cites W2157921426 @default.
• W1981866712 cites W2174636332 @default.
• W1981866712 cites W2269605635 @default.
• W1981866712 doi "https://doi.org/10.1097/cej.0b013e328353ed81" @default.
• W1981866712 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3449013" @default.
• W1981866712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22609636" @default.
• W1981866712 hasPublicationYear "2013" @default.
• W1981866712 type Work @default.
• W1981866712 sameAs 1981866712 @default.
• W1981866712 citedByCount "13" @default.
• W1981866712 countsByYear W19818667122013 @default.
• W1981866712 countsByYear W19818667122014 @default.
• W1981866712 countsByYear W19818667122016 @default.
• W1981866712 countsByYear W19818667122017 @default.
• W1981866712 countsByYear W19818667122018 @default.
• W1981866712 countsByYear W19818667122020 @default.
• W1981866712 countsByYear W19818667122022 @default.
• W1981866712 crossrefType "journal-article" @default.
• W1981866712 hasAuthorship W1981866712A5003315698 @default.
• W1981866712 hasAuthorship W1981866712A5009081262 @default.
• W1981866712 hasAuthorship W1981866712A5010788589 @default.
• W1981866712 hasAuthorship W1981866712A5014827216 @default.
• W1981866712 hasAuthorship W1981866712A5021330317 @default.
• W1981866712 hasAuthorship W1981866712A5039423116 @default.
• W1981866712 hasAuthorship W1981866712A5041301571 @default.
• W1981866712 hasAuthorship W1981866712A5044087654 @default.
• W1981866712 hasAuthorship W1981866712A5070534421 @default.
• W1981866712 hasAuthorship W1981866712A5087485359 @default.
• W1981866712 hasAuthorship W1981866712A5087598755 @default.
• W1981866712 hasBestOaLocation W19818667121 @default.
• W1981866712 hasConcept C120863210 @default.
• W1981866712 hasConcept C126322002 @default.
• W1981866712 hasConcept C134018914 @default.
• W1981866712 hasConcept C147583825 @default.
• W1981866712 hasConcept C167734588 @default.
• W1981866712 hasConcept C2776871010 @default.
• W1981866712 hasConcept C2777025900 @default.
• W1981866712 hasConcept C2779184299 @default.
• W1981866712 hasConcept C2780586474 @default.

• next